Neuropharmacological Intervention for Severe Mental Illness and Suicide Prevention

3,289
Total downloads
10k
Total views and downloads

Articles

REVIEW

Published on 24 Feb 2025

Ferroptosis, pathogenesis and therapy in AS co-depression disease

Yulong Zhao
Peng Ren
Qiang Luo
Xue Li
Xinyi Cheng
Youliang Wen
Xiaoyun Wu
Junjie Zhou

doi 10.3389/fphar.2025.1516601

222 views

ORIGINAL RESEARCH

Accepted on 19 Feb 2025

Purinergic receptor antagonism reduces interictal discharges and rescues cognitive function in a mouse model of temporal lobe epilepsy

Nelson Espinosa
Soraya Martin-Suarez
Ariel Lara-Vasquez
Trinidad Montero
Teresa Muro- García
German Fernandez
Juan Manuel Encinas-Pérez
Pablo Fuentealba

doi 10.3389/fnins.2025.1513135

100 views

REVIEW

Published on 27 Jan 2025

Trends in research on novel antidepressant treatments

Agnieszka Zelek-Molik
Ewa Litwa

doi 10.3389/fphar.2025.1544795

884 views

ORIGINAL RESEARCH

Published on 06 Jan 2025

Restraint stress effects on glutamate signaling protein levels in the rats’ frontal cortex: Does β1 adrenoceptor activity matter?

Agnieszka Zelek-Molik
Anna Gądek-Michalska
Michał Wilczkowski
Adam Bielawski
Katarzyna Maziarz
Grzegorz Kreiner
Irena Nalepa

doi 10.3389/fphar.2024.1451895

299 views
1 citation

REVIEW

Published on 17 Oct 2024

The role of exercise-related FNDC5/irisin in depression

Yaqi Liu
Xiying Fu
Xing Zhao
Ranji Cui
Wei Yang

doi 10.3389/fphar.2024.1461995

1,352 views
2 citations

ORIGINAL RESEARCH

Published on 07 Aug 2024

The forensic aspects of suicide and neurotrophin factors: a research study

Stefania De Simone
Letizia Alfieri
Maria Antonella Bosco
Santina Cantatore
Michele Carpinteri
Luigi Cipolloni
Margherita Neri

doi 10.3389/fphar.2024.1392832

683 views

CASE REPORT

Published on 18 Jul 2024

Case report: Dezocine’s rapid and sustained antidepressant effects

Han Wang
Nan Lyu
Qian Zhao

doi 10.3389/fphar.2024.1411119

749 views

CASE REPORT

Published on 21 Jun 2024

Case report: Time response of plasma clozapine concentrations on cessation of heavy smoking

Lingyan Qi
Botao Ma
Hongzhen Fan
Siyuan Qi
Fude Yang
Huimei An

doi 10.3389/fphar.2024.1408915

644 views

CLINICAL TRIAL

Published on 24 May 2024

Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study

Khlood Mohammad Aldossary
Lashin Saad Ali
Mahmoud S. Abdallah
Mostafa M. Bahaa
Thanaa A. Elmasry
Eman I. Elberri
Fedaa A. Kotkata
Ramy M. El Sabaa
Yasmine M. Elmorsi
7 more
Manal A. Hamouda

doi 10.3389/fphar.2024.1381523

1,481 views
1 citation

ORIGINAL RESEARCH

Published on 06 Feb 2024

Artemisinin reduces PTSD-like symptoms, improves synaptic plasticity, and inhibits apoptosis in rats subjected to single prolonged stress

Qing Liu
Xiaoyan Ding
Ying Wang
Hairong Chu
Yan Guan
Meng Li
Kuisheng Sun

doi 10.3389/fphar.2024.1303123

1,419 views
2 citations

Share on

Frontiers in Pharmacology

Neuropharmacology

Participating Journals

Frontiers in Neuroscience
- Neuropharmacology
- 3.2 impact factor
- 6.2 citescore

Impact

10kTopic views
6,833Article views
3,289Article downloads

View impact

Articles

Ferroptosis, pathogenesis and therapy in AS co-depression disease

Purinergic receptor antagonism reduces interictal discharges and rescues cognitive function in a mouse model of temporal lobe epilepsy

Trends in research on novel antidepressant treatments

Restraint stress effects on glutamate signaling protein levels in the rats’ frontal cortex: Does β1 adrenoceptor activity matter?

The role of exercise-related FNDC5/irisin in depression

The forensic aspects of suicide and neurotrophin factors: a research study

Case report: Dezocine’s rapid and sustained antidepressant effects

Case report: Time response of plasma clozapine concentrations on cessation of heavy smoking

Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study

Artemisinin reduces PTSD-like symptoms, improves synaptic plasticity, and inhibits apoptosis in rats subjected to single prolonged stress

Frontiers in Pharmacology

Neuropharmacology

Participating Journals

Frontiers in Neuroscience

Neuropharmacology